To continue reading this article, sign up for FREE to
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Already a member? Login Here
CardioTech to sell biomedical unit
CardioTech International Inc. on Thursday said it will sell its Gish Biomedical Unit after the company posted a narrower third quarter loss.
CardioTech's CEO, Michael Adams, called the biomedical unit a "great bus
Written byLab Manager
Lab Manager provides guidance and resources to help laboratory leaders run their labs like a business. We are the only publication specifically focused on all aspects of running a lab.
Learn about our Editorial Policies.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
